HomeLarge Type Edition
HOME ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
PubMed
Right arrow PubMed Citation
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 61:1281-1286 (2006)
© 2006 The Gerontological Society of America


SPECIAL SECTION

Review Article

Serum Biomarkers for Delirium

Edward R. Marcantonio, James L. Rudolph, Deborah Culley, Gregory Crosby, David Alsop and Sharon K. Inouye

1 Division of General Medicine and Primary Care, 2 Department of Radiology, and 3 Division of Gerontology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
4 Department of Anesthesia and 5 Division of Aging, Brigham and Women's Hospital, Boston, Massachusetts.
6 Aging Brain Center, Hebrew SeniorLife, Boston, Massachusetts.
7 Geriatrics Research, Education and Clinical Center, Boston Veteran's Administration Medical Center, Massachusetts.
8 Harvard Medical School, Boston, Massachusetts.

Address correspondence to Edward R. Marcantonio, MD, SM, Beth Israel Deaconess Medical Center, 1309 Beacon St., Rm. 218, Brookline, MA 02446. E-mail: emarcant{at}bidmc.harvard.edu

This narrative review examines serum biomarkers for the diagnosis and monitoring of delirium. Serum biomarkers for delirium fall into three major groups: 1) those that are present or elevated prior to disease onset—risk markers, 2) those that rise with onset and fall with recovery—disease markers, and 3) those that rise in proportion to the consequences of disease—end products. As risk markers, we examine serum chemistries and genetic risk markers. As disease markers, we examine serum anticholinergic activity, amino acids, melatonin, cytokines, cortisol, and gene expression. As end products of delirium, we examine markers of neuronal injury. Finally, we discuss methodological and biostatistical considerations for future biomarker studies. Identifying accurate biomarkers for delirium may shed further light into its pathophysiology and on the interrelationship between delirium and dementia.




This article has been cited by other articles:


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
T. T. Hshieh, T. G. Fong, E. R. Marcantonio, and S. K. Inouye
Cholinergic Deficiency Hypothesis in Delirium: A Synthesis of Current Evidence
J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2008; 63(7): 764 - 772.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
J. L. Rudolph, B. Ramlawi, G. A. Kuchel, J. E. McElhaney, D. Xie, F. W. Sellke, K. Khabbaz, S. E. Levkoff, and E. R. Marcantonio
Chemokines Are Associated With Delirium After Cardiac Surgery
J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2008; 63(2): 184 - 189.
[Abstract] [Full Text] [PDF]


Home page
Age AgeingHome page
S. Speciale, G. Bellelli, F. Guerini, and M. Trabucchi
C-reactive protein levels and delirium in a rehabilitation ward
Age Ageing, January 1, 2008; 37(1): 122 - 123.
[Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
S. K. Inouye and L. Ferrucci
Introduction: Elucidating the Pathophysiology of Delirium and the Interrelationship of Delirium and Dementia
J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2006; 61(12): 1277 - 1280.
[Full Text] [PDF]




HOME ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by The Gerontological Society of America.